Division of Nephrology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Institute for Genomic Medicine, Columbia University, New York, NY, USA.
Nat Rev Nephrol. 2020 Nov;16(11):641-656. doi: 10.1038/s41581-020-0325-2. Epub 2020 Aug 17.
Although often considered a single-entity, chronic kidney disease (CKD) comprises many pathophysiologically distinct disorders that result in persistently abnormal kidney structure and/or function, and encompass both monogenic and polygenic aetiologies. Rare inherited forms of CKD frequently span diverse phenotypes, reflecting genetic phenomena including pleiotropy, incomplete penetrance and variable expressivity. Use of chromosomal microarray and massively parallel sequencing technologies has revealed that genomic disorders and monogenic aetiologies contribute meaningfully to seemingly complex forms of CKD across different clinically defined subgroups and are characterized by high genetic and phenotypic heterogeneity. Investigations of prevalent genomic disorders in CKD have integrated genetic, bioinformatic and functional studies to pinpoint the genetic drivers underlying their renal and extra-renal manifestations, revealing both monogenic and polygenic mechanisms. Similarly, massively parallel sequencing-based analyses have identified gene- and allele-level variation that contribute to the clinically diverse phenotypes observed for many monogenic forms of nephropathy. Genome-wide sequencing studies suggest that dual genetic diagnoses are found in at least 5% of patients in whom a genetic cause of disease is identified, highlighting the fact that complex phenotypes can also arise from multilocus variation. A multifaceted approach that incorporates genetic and phenotypic data from large, diverse cohorts will help to elucidate the complex relationships between genotype and phenotype for different forms of CKD, supporting personalized medicine for individuals with kidney disease.
虽然慢性肾脏病 (CKD) 通常被认为是一种单一实体疾病,但它实际上包含许多在病理生理学上有明显区别的疾病,这些疾病导致肾脏结构和/或功能持续异常,包括单基因和多基因病因。罕见的遗传性 CKD 形式通常跨越多种表型,反映了包括多效性、不完全外显率和表现度变异在内的遗传现象。使用染色体微阵列和大规模平行测序技术已经表明,基因组疾病和单基因病因对不同临床定义亚组中看似复杂的 CKD 形式有重要贡献,并且具有高度的遗传和表型异质性。对 CKD 中常见基因组疾病的研究综合了遗传、生物信息学和功能研究,以确定其肾脏和肾脏外表现的遗传驱动因素,揭示了单基因和多基因机制。同样,基于大规模平行测序的分析确定了导致许多单基因形式肾病观察到的临床多样化表型的基因和等位基因变异。全基因组测序研究表明,在确定疾病遗传原因的患者中,至少有 5% 存在双重遗传诊断,这突出了一个事实,即复杂的表型也可能源于多基因座变异。一种多方面的方法,将来自大型、多样化队列的遗传和表型数据结合起来,将有助于阐明不同形式的 CKD 中基因型和表型之间的复杂关系,为肾脏病患者的个体化医学提供支持。